Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://link.springer.com/doi/10.1007/s00213-003-1740-3 below:

Brain concentrations of d-MDMA are increased after stress

• Anakk S, Kalsotra A, Shen Q, Vu MT, Staudinger JL, Davies PJ, Strol HW (2003) Genomic characterization and regulation of Cyp3a13: role of xenobiotics and nuclear receptors. FASEB J 17:1736–1738

  CAS  PubMed  Google Scholar 

• Blume N, Leonard J, Xu ZJ, Watanabe O, Remotti H, Fishman J (2000) Characterization of Cyp2d22, a novel cytochromes P450 expressed in mouse mammary cells. Arch Biochem Biophys 381:191–204

  Article  CAS  PubMed  Google Scholar 

• Camarero J, Sanchez V, O’Shea E, Green AR, Colado MI (2002) Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR12909 on 3,4-methylenedioxymethamphetamine (“ecstasy”)-induced dopamine release and free radical formation in the mouse striatum. J Neurochem 81:961–972

  Article  PubMed  Google Scholar 

• Carson EJ, Pruett SB (1996) Development and characterization of a binge drinking model in mice for evaluation of the immunological effects of ethanol. Alcohol Clin Exp Res 20:132–138

  CAS  PubMed  Google Scholar 

• Chiba K, Trevor A, Castagnoli N JR (1984) Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem Biophys Res Commun 120:574–578

  CAS  PubMed  Google Scholar 

• Cho AK, Hiramatsu M, Distefano EW, Chang AS, Jenden DJ (1990) Stereochemical differences in the metabolism of 3,4-methylenedioxymethamphetamine in vivo and in vitro: a pharmacokinetic analysis. Drug Metab Dispos 18:686–691

  CAS  PubMed  Google Scholar 

• Christians U, Schmidt G, Bader A, Lampen A, Schottmann R, Linck A, Sewing KF (1996), Identification of drugs inhibiting the in vitro metabolism of tacrolimus by human liver microsomes. Br J Clin Pharmacol 41:187–190

  CAS  PubMed  Google Scholar 

• Clausing P, Gough B, Holson RR, Slikker W Jr., Bowyer JF, (1995) Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects. J Pharmacol Exp Ther 274:614–621

  CAS  PubMed  Google Scholar 

• Colado MI, Camarero J, Mechan AO, Sanchez V, Estaban B, Elliot JM, Green AR (2001) A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) on dopamine neurons in mouse brain. Br J Pharmacol 134:1711–1723

  CAS  PubMed  Google Scholar 

• Dafters RI, Lynch E (1998) Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or “ecstasy”) but not by fenfluramine. Psychopharmacology 138:207–212

  CAS  PubMed  Google Scholar 

• Esteban B, O’Shea E, Camarero J, Sanchez V, Green AR, Colado MI (2001) 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Psychopharmacology 154:251–260

  Article  CAS  PubMed  Google Scholar 

• Gordon C (1993) Temperature regulation in laboratory rodents. Cambridge University Press, New York

• Iber H, Chen Q, Sewer M, Morgan ET (1997) Regulation of hepatic cytochrome P450 2C11 by glucocorticoids. Arch Biochem Biophys 345:305–310

  Article  CAS  PubMed  Google Scholar 

• Johnson EA, Miller DB (2001) Restraint and other stress manipulations are neuroprotective against the effects of 3,4-methylenedioxymethamphetamine (d-MDMA) in C57Bl/6 J mouse because of altered distribution. Soc Neuroscience Abstr vol 27, Program no. 175.15

• Johnson EA, Sharp DS, Miller DB (2000) Restraint as a stressor in mice: against the dopaminergic neurotoxicity of d-MDMA, low body weight mitigates restraint-induced hypothermia and consequent neuroprotection. Brain Res 875:107–118

  Article  CAS  PubMed  Google Scholar 

• Johnson EA, O’Callaghan JP, Miller DB (2002) Chronic treatment with supraphysiological levels of corticosterone enhances D-MDMA-induced dopaminergic neurotoxicity in the C57Bl/6J female mouse. Brain Res 933:130–138

  Article  CAS  PubMed  Google Scholar 

• Kreth KP, Kovar KA, Schwab M, Zanger UM, (2000) Identification of the human cytochromes P450 Involved in the oxidative metabolism of “ecstasy”-related designer drugs. Biochem Pharmacol 59:1563–1571

  CAS  PubMed  Google Scholar 

• Lampen A, Christians U, Guengerich FP, Watkins PB, Kolars JC, Bader A, Gonschior AK, Dralle H, Hackbarth I, Sewing KF, (1995) Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability. Drug Metab Dispos 23:1315–1324

  CAS  PubMed  Google Scholar 

• Lin LY, Di Stefano EW, Schmitz DA, Hsu L, Ellis SW, Lennard MS, Tucker GT, Cho AK, (1997) Oxidation of methamphetamine and methylendioxymethamphetamine by CYP2D6. Drug Metab Dispos 25:1059–1064

  CAS  PubMed  Google Scholar 

• Markey SP, Johannessen JN, Chiueh CC, Burns RS, Herkenham MA (1984) Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism in primates. Nature 311:464–467

  CAS  PubMed  Google Scholar 

• Maurer HH, Bickeboeller-Friedrich J, Kraemer T, Peters FT, (2000) Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs (ecstasy). Toxicol Lett 112–113:133–142

  Google Scholar 

• Miller DB, O’Callaghan JP (1994) Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:752–760

  Google Scholar 

• Miller DB, O’Callaghan JP (1995) The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine. Mol Neurobiol 11:177–192

  CAS  PubMed  Google Scholar 

• Molliver ME, O’Hearn E, Battaglia G, DeSouza ER (1986) Direct intracerebral administration of MDMA and MDA does not produce serotonin neurotoxicity. Soc Neurosci Abstr 12:1234

  Google Scholar 

• Nixdorf WL, Burrows KB, Gudelsky GA, Yamamoto BK (2001) Enhancement of 3/4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor amalonate. J Neurochem 77:647–654

  Article  CAS  PubMed  Google Scholar 

• O’Callaghan JP (2002) Measurement of glial fibrillary acidic protein. In: Costa LG (ed) Current protocols in toxicology. Wiley, New York, pp 12.81.1–12.8.12

• O’Callaghan JP, Miller DB (1994) Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:741–751

  Google Scholar 

• O’Callaghan JP, Miller DB (2002) Neurotoxic effects of Substituted amphetamines in mice and rats: challenges to the current doga. In: Massaro EJ (ed) Handbook of neurotoxicology vol II. Humana Press, Totawa, N.J., pp 269–301

• O’Loinsigh ED, Boland G, Kelly JP, O’Boyle KM (2001) Behavioral, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat. Prog Neurpsychopharmacol Biol Psychiatry 25:621–638

  Article  CAS  Google Scholar 

• O’Shea E, Esteban B, Camarero J, Green AR, Colado, MI (2001) Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA (“ecstasy”) on the 5-HT and dopamine concentrations in mouse brain. Neuropharmacology 40:65–74

  Google Scholar 

• Paris JM, Cunningham KA (1992) Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA). Brain Res Bull 28:115–119

  Article  CAS  PubMed  Google Scholar 

• Pruett SB, Collier SD, Wu WJ (1998) Ethanol-induced activation of the hypothalamic-pituitary-adrenal axis in a mouse model for binge drinking: role of R015-4513-sensitive gamma aminobutyric acid receptors, tolerance and relevance to humans. Life Sci 63:1137–1146

  Article  CAS  PubMed  Google Scholar 

• Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner RH, Provenzano MD, Fujimoto EK, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85

  PubMed  Google Scholar 

• Tallarida RJ, Murray RB (1987) Manual of pharmacologic calculations with computer programs, Springer-Verlag, New York, pp 77–81

• Tucker GT, Lennard MS, Ellis SW, Woods HF, Cho AK, Lin LY, Hiratsuka A, Schmitz DA, Chu TYY (1994) The demethylenation of methylenedioxymethamphetamine (“ecstasy”) by debrisoquine hydroxylase (CYP2D6), Biochem Pharmacol 47:1151–1156

  Google Scholar 

• Wu D, Otton SV, Inaba T, Kalow W, Sellers EM (1997) Interactions of amphetamine analogs with human liver CYP2D6. Biochem Pharmacol 53:1605–1612

  CAS  PubMed  Google Scholar 

Download references

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.4